Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Strategies for Preventing Antimicrobial Resistance

By HospiMedica staff writers
Posted on 01 Apr 2002
A campaign to prevent antimicrobial resistance in healthcare settings was announced by the US Centers for Disease Control and Prevention (Atlanta, USA) at the International Conference on Emerging Infectious Diseases in Atlanta.

The campaign comprises four key strategies. More...
These are to prevent infection, diagnose and treat infection effectively, use antimicrobials wisely, and prevent the transmission of drug-resistant pathogens. Within these strategies are 12 specific action steps derived from evidence-based guidelines and recommendations that clinicians can use to prevent antimicrobial resistance in hospitalized adults.

Action Step 1 is to give influenza/S pneumonia vaccine to at-risk patients before discharge. Step 2 is to use catheters only when essential and remove them when no longer essential. Step 3 is to culture the patient, target empiric therapy to likely pathogens, and target definitive therapy to known pathogens. Step 4 is to consult infectious disease experts for patients with serious infections. Step 5 is to engage in local antimicrobial control. Step 6 is to know your antibiogram.

Step 7 is to treat infection, not contamination. Step 8 is to treat infection, not colonization. Step 9 is to know when to say "no” to vancomycin. Step 10 is to stop antimicrobial treatment when infection is treated or unlikely. Step 11 is to use standard infection control precautions, contain infectious body fluids, and consult infection control experts when in doubt. Step 12 is to break the chain of contagion by staying home when sick, keeping hands clean, and setting an example.

Antimicrobial resistant infections in healthcare settings are a major threat to patient safety. Each year in the United States alone, an estimated 2 million hospitalized patients acquire infections that result in more than 90,000 deaths. More than half are caused by bacteria that are resistant to at least one of the antimicrobials commonly used to treat those infections, says the CDC.

"We are confident that this campaign will help prevent the emergence and spread of antimicrobial resistance in healthcare settings and make healthcare in the United States even safer than it is today,” said Dr. Julie Gerberding, director of the CDC campaign.




Related Links:
CDC

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.